On-Demand Webinar Archives

On-Demand Webinar

PBPK modeling approaches to assess risks associated with bioequivalence in drug development

In this webinar, Dr. Ioannis Loisios-Konstantinidis from Novartis, Switzerland discussed: Opportunities and challenges in conducting…

CertaraMay 19, 2021

On-Demand Webinar

Evidence generation in Europe- How valuable is the French National administrative health data (SNDS)

Watch this presentation to learn • Overview of the SNDS and the key working practices…

CertaraMay 7, 2021

On-Demand Webinar

The Wizard of Oligos: There’s no place like having a successful drug development program!

Oligonucleotide therapies— nucleic acid polymers with the potential to treat or manage a wide range…

CertaraApril 30, 2021

On-Demand Webinar

The Promises and Pitfalls of Gene Therapy for Rare Diseases

The state of gene therapy faces much uncertainty as recent regulatory and clinical setbacks have…

CertaraApril 29, 2021

On-Demand Webinar

Part 3: Oligonucleotide therapeutic development: Clinical pharmacology considerations

In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…

CertaraApril 21, 2021

On-Demand Webinar

Part 2: Oligonucleotide therapeutic development: Pre-clinical and translational considerations

In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…

CertaraApril 21, 2021

On-Demand Webinar

Part 1: What are oligonucleotide therapeutics, and how do they work?

In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…

CertaraApril 21, 2021

On-Demand Webinar

Plan to Accelerate Your Time to Drug Submissions

There are common themes driving how quickly you can get from your last database lock…

CertaraApril 20, 2021

On-Demand Webinar

A Best Practice Framework for Applying PBPK Modeling to Pediatric Drug Development

Pediatric PBPK models have broad application in the drug development process and are being used…

CertaraApril 20, 2021

On-Demand Webinar

Predicting the Effect of the Dulaglutide-Mediated Gastric Emptying Delay on Drug Exposure

The European Medicines Agency (EMA) recently approved dulaglutide (Trulicity®) at higher doses (3 mg and…

CertaraApril 1, 2021

On-Demand Webinar

PBPK modeling approaches to assess risks associated with bioequivalence in drug development

Evidence generation in Europe- How valuable is the French National administrative health data (SNDS)

The Wizard of Oligos: There’s no place like having a successful drug development program!

The Promises and Pitfalls of Gene Therapy for Rare Diseases

Part 3: Oligonucleotide therapeutic development: Clinical pharmacology considerations

Part 2: Oligonucleotide therapeutic development: Pre-clinical and translational considerations

Part 1: What are oligonucleotide therapeutics, and how do they work?

Plan to Accelerate Your Time to Drug Submissions

A Best Practice Framework for Applying PBPK Modeling to Pediatric Drug Development

Predicting the Effect of the Dulaglutide-Mediated Gastric Emptying Delay on Drug Exposure

Newsletter sign up

Quick links

Solutions

Contact